tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:0MTD Stock Latest News

Swedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays
The FlySwedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays
28d ago
Swedish Orphan Biovitrum price target raised to SEK 500 from SEK 470 at Berenberg
PremiumThe Fly
Swedish Orphan Biovitrum price target raised to SEK 500 from SEK 470 at Berenberg
28d ago
Swedish Orphan Biovitrum downgraded to Hold from Buy at Danske Bank
PremiumThe Fly
Swedish Orphan Biovitrum downgraded to Hold from Buy at Danske Bank
1M ago
Sobi Sets Ambitious 2030 Target to Double Revenue on Wave of New Rare-Disease Launches
PremiumCompany Announcements
Sobi Sets Ambitious 2030 Target to Double Revenue on Wave of New Rare-Disease Launches
1M ago
Swedish Orphan upgraded to Outperform from Underperform at BNP Paribas
PremiumThe Fly
Swedish Orphan upgraded to Outperform from Underperform at BNP Paribas
1M ago
Sobi Posts Strong 2025 Growth and Expands Rare Disease Portfolio With Strategic Deals and Launches
PremiumCompany AnnouncementsSobi Posts Strong 2025 Growth and Expands Rare Disease Portfolio With Strategic Deals and Launches
2M ago
Swedish Orphan Biovitrum Ab (0MTD) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Swedish Orphan Biovitrum Ab (0MTD) Q4 Earnings Cheat Sheet
2M ago
Sobi Lifts 2025 Revenue and Profitability Above Previous Outlook
Premium
Company Announcements
Sobi Lifts 2025 Revenue and Profitability Above Previous Outlook
2M ago
PremiumCompany Announcements
Sobi Advances Gamifant After Positive Phase 2a Data in Interferon-Gamma–Driven Sepsis
3M ago
Swedish Orphan Biovitrum Ab Completes Key Study on Still’s Disease in Italy
PremiumCompany Announcements
Swedish Orphan Biovitrum Ab Completes Key Study on Still’s Disease in Italy
3M ago
0MTD
Sobi Acquires Arthrosi Therapeutics to Strengthen Gout Treatment Pipeline
PremiumCompany Announcements
Sobi Acquires Arthrosi Therapeutics to Strengthen Gout Treatment Pipeline
3M ago
Swedish Orphan Biovitrum’s Phase 3 Study on Pacritinib: A Potential Game-Changer for Myelofibrosis Treatment
PremiumCompany Announcements
Swedish Orphan Biovitrum’s Phase 3 Study on Pacritinib: A Potential Game-Changer for Myelofibrosis Treatment
5M ago
0MTD
Swedish Orphan Biovitrum’s PAXIS Study: A Potential Breakthrough for VEXAS Syndrome
PremiumCompany AnnouncementsSwedish Orphan Biovitrum’s PAXIS Study: A Potential Breakthrough for VEXAS Syndrome
5M ago
0MTD
Swedish Orphan Biovitrum’s New Study on Hemophilia A Treatment: A Potential Game Changer?
Premium
Company Announcements
Swedish Orphan Biovitrum’s New Study on Hemophilia A Treatment: A Potential Game Changer?
5M ago
0MTD
Swedish Orphan Biovitrum Advances Haemophilia A Treatment with Ongoing Study
Premium
Company Announcements
Swedish Orphan Biovitrum Advances Haemophilia A Treatment with Ongoing Study
5M ago
0MTD
Swedish Orphan Biovitrum’s Promising Phase 4 Study on Haemophilia A Treatment
PremiumCompany Announcements
Swedish Orphan Biovitrum’s Promising Phase 4 Study on Haemophilia A Treatment
5M ago
0MTD
Swedish Orphan Biovitrum’s New Study on Still’s Disease: Market Implications and Insights
PremiumCompany Announcements
Swedish Orphan Biovitrum’s New Study on Still’s Disease: Market Implications and Insights
5M ago
0MTD
Swedish Orphan Biovitrum’s New Study on Anakinra: A Potential Game-Changer for FMF Treatment
PremiumCompany Announcements
Swedish Orphan Biovitrum’s New Study on Anakinra: A Potential Game-Changer for FMF Treatment
5M ago
0MTD
IQVIA and Swedish Orphan Biovitrum’s PNH Study: A Potential Game-Changer for Pegcetacoplan
PremiumCompany Announcements
IQVIA and Swedish Orphan Biovitrum’s PNH Study: A Potential Game-Changer for Pegcetacoplan
5M ago
IQV
Swedish Orphan Biovitrum’s Promising Study on Efanesoctocog Alfa for Haemophilia A
PremiumCompany AnnouncementsSwedish Orphan Biovitrum’s Promising Study on Efanesoctocog Alfa for Haemophilia A
5M ago
0MTD
Swedish Orphan Biovitrum’s Nitisinone Study: A Closer Look at HT-1 Treatment Outcomes
Premium
Company Announcements
Swedish Orphan Biovitrum’s Nitisinone Study: A Closer Look at HT-1 Treatment Outcomes
5M ago
0MTD
Helena Saxon Resigns from Sobi Board of Directors
Premium
Company Announcements
Helena Saxon Resigns from Sobi Board of Directors
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >